Sep 16, 2026 08:00AM
Sep 16, 2026 08:00AM
Jul 31, 2026 01:08AM
Jul 30, 2026 04:07PM
Jul 30, 2026 04:05PM
Jul 23, 2026 09:05AM
May 6, 2026 02:50AM Myriad Genetics (MYGN) Misses Q1 EPS by 2c ; Offers Guidance
May 5, 2026 04:05PM
Apr 28, 2026 04:05PM
Feb 23, 2026 04:16PM
Feb 23, 2026 04:05PM
Feb 16, 2026 04:15PM
Jan 12, 2026 08:32AM
Jan 12, 2026 08:30AM Myriad Genetics Announces Select Preliminary Fourth Quarter and Full Year 2025 Financial Results and Introduces Full Year 2026 Financial Guidance
Nov 3, 2025 04:44PM
Nov 3, 2025 04:05PM
Nov 3, 2025 04:05PM
Oct 27, 2025 04:15PM
Aug 18, 2025 08:30AM
Aug 18, 2025 08:30AM
Aug 5, 2025 04:36PM Myriad Genetics (MYGN) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY25 Guidance
Aug 5, 2025 04:05PM
Jul 31, 2025 08:30AM
Jul 31, 2025 08:30AM
Jul 29, 2025 04:05PM
Jul 25, 2025 12:02PM
May 7, 2025 12:46AM
May 6, 2025 04:05PM Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
Apr 29, 2025 09:00AM
Feb 24, 2025 05:02PM
Feb 24, 2025 04:07PM
Feb 24, 2025 04:05PM
Feb 24, 2025 04:05PM
Feb 18, 2025 08:30AM
Jan 15, 2025 09:00AM Diligent Announces Market Insights Reporting Powered by S&P Global Market Intelligence, Giving Directors and Executives Unrivaled Financial and Risk Insights
Jan 15, 2025 08:32AM
Jan 15, 2025 08:30AM
Dec 10, 2024 06:26PM
Nov 7, 2024 04:46PM
Nov 7, 2024 04:05PM
Nov 4, 2024 08:40AM
Nov 4, 2024 08:39AM Myriad Genetics Comments on UnitedHealthcare’s Updated Medical Policy for Pharmacogenetic Testing
Oct 30, 2024 08:00AM
Oct 1, 2024 06:47AM
Aug 6, 2024 04:05PM
Jul 30, 2024 08:00AM
May 30, 2024 05:55PM
May 30, 2024 04:05PM
May 7, 2024 04:05PM Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
Apr 30, 2024 04:05PM

1,225,841 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All